On January 23, 2017, President Trump signed a memorandum reinstating the Mexico City Policy, a Reagan-era restriction that prohibits U.S. federal funding to foreign non-governmental organizations offering abortion services or information about abortion. The policy, formally titled the "Memorandum on Promoting the Global Gag Rule," uses the president's spending authority to condition federal aid on compliance with this abortion restriction. The mechanism is straightforward: any international organization receiving U.S. government funds—whether through the State Department, USAID, or other federal agencies—must certify that it will not perform abortions or provide abortion counseling, regardless of local laws or medical necessity.

The policy's reach is substantial and concrete. Organizations like Planned Parenthood International, Marie Stopes International, and dozens of smaller family planning nonprofits operating in Africa, Asia, and Latin America face immediate funding cuts. Women in developing countries lose access to reproductive healthcare services because these organizations often serve as primary providers for contraception, maternal health screening, sexually transmitted infection testing, and cancer screenings. In countries with restrictive abortion laws, the policy creates perverse incentives: organizations must choose between providing comprehensive family planning services or receiving U.S. funding. Many reduce operations or close entirely, leaving healthcare deserts in regions already facing maternal mortality crises.

This action reflects a consistent pattern in Trump administration foreign policy prioritizing ideological conditions over humanitarian outcomes. While the related actions in the archive focus on military escalation and sanctions—the $8.6 billion arms deals, Iran blockade deployments, and cartel restrictions—they share a common thread of using foreign policy mechanisms to enforce domestic political preferences. The Mexico City Policy similarly instrumentalizes foreign aid to advance abortion restrictions that would be constitutionally questionable if imposed domestically.

The policy remains legally active. Multiple lawsuits have challenged its constitutionality, and Congress has attempted to restrict its scope through appropriations riders, but the executive memorandum has proven durable across administrations. Reversal would require either a new presidential memorandum or congressional action codifying protections for comprehensive reproductive healthcare funding abroad.